![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, August 26, 2021 1:25:12 PM
I would guess the next steps are they pivot from pure nanoviricide to nanoviricide as carrier, similar to what they did with their CovidCide-remdesivir. Maybe they might even get a partner to improve on their partner's drug via new delivery (if nanoviricide encapsulation works to deliver payload into select cells - probably doing the preclinical work now). Then Diwan will release some promising lab studies and negotiate a big license with himself to pursue the next greatest thing, if he can find anybody left to give him money.
Or maybe they will release some more CoV results and report on what else they need to do for a CovidCide IND. Then Covid will be over by the time that work is completed, and they will resume topical HerpeCide development.
In the meantime, there are so many other impressive technologies out there that show promise to be able to dismantle viruses like NNVC purports to be able to do (but just can't manufacture reproducibly and cost effectively?). How about Maxwell Biosciences and their peptoids? Nice viral destruction:
https://www.mdpi.com/1424-8247/14/4/304/htm
Something will be created to be able to destroy viruses and will be very successful, but I doubt it will come from NNVC at this point. Expectations are low, but would love to be surprised.
What about you?
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM